Medical Condition News

RSS

iTech Medical receives Health Canada approval for Muscle Pattern Recognition System

iTech Medical, Inc., a medical information technology company, announced today that it has received Health Canada approval for the Company's Muscle Pattern Recognition (MPR) System, a non-invasive clinical assessment tool being developed to assist in the diagnosis and treatment of back and neck pain, one of the most common chronic conditions in Canada.

13 Dec 2010

Ascension Orthopedics reports first implantation of PyroTITAN Humeral Resurfacing Implant in France

Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Implant in France. The PyroTITAN was implanted in a 68-year-old patient suffering from painful primary arthritis with synovial osteochondromotosis at Imperial Park Clinic in Nice – making it a surgical first in continental Europe. The patient was discharged from the hospital the next day and reported good pain relief 10 days after surgery.

13 Dec 2010

New positive data on Generex Oral-lyn published in Diabetes, Obesity and Metabolism

Generex Biotechnology Corporation announced today that the peer-reviewed scientific journal Diabetes, Obesity and Metabolism has published new positive data in respect of Generex Oral-lyn™, the Company's proprietary buccal insulin spray product.

13 Dec 2010

Fracture risk assessment tool for Singaporeans released

Today, the International Osteoporosis Foundation (IOF) and the World Health Organization Collaborating Centre for Metabolic Bone Diseases at the University of Sheffield, UK announced the launch of a FRAX- calculator for Singapore.

13 Dec 2010

Vical's Vaxfectin adjuvant boosts immune response of DNA-based vaccines against cancer

Vical Incorporated announced today that the company's Vaxfectin® adjuvant has significantly boosted the immune response of DNA-based vaccines against a range of pathogens and cancer in preclinical models from rodents to non-human primates. Vaxfectin® has demonstrated similar effects with protein- and peptide-based vaccines in preclinical models.

13 Dec 2010

Stimatix GI's AOS-C1000 colostomy management device meets primary, secondary endpoints in pre-clinical studies

Stimatix GI reported that the AOS-C1000(TM), a unique colostomy management device, met primary and secondary endpoints in pre-clinical in-vivo animal studies. The study was conducted under the direction of Dr. Ron Greenberg, Senior Surgeon, Department of Surgery, Sourasky Medical Center, Tel Aviv Israel. Primary endpoints of repeatable stoma sealing for continence control as well as secondary endpoints regarding tissue pathology and survival were met confirming the AOS-C1000(TM) as capable of enabling repeatable colostomy site (stoma) sealing for continence control.

13 Dec 2010

Man Up Now capsules can dangerously lower blood pressure

Product marketed for sexual enhancement contains potentially dangerous ingredient The U.S. Food and Drug Administration is warning consumers not to use Man Up Now capsules, marketed as a dietary supplement for sexual enhancement, because they contain a variation of an active drug ingredient found in Viagra that can dangerously lower blood pressure.

13 Dec 2010

School children who dislike fruits and vegetables are more likely to develop functional constipation

Primary school children who don't like eating fruit and vegetables are 13 times more likely to develop functional constipation than children who do, according to a study in the December issue of the Journal of Clinical Nursing. Drinking less than 400ml of fluid a day also significantly increases the risk.

13 Dec 2010

Researchers examine outcomes related to antiplatelet therapy in patients undergoing CEA

Despite the common clinical practice among surgeons to discontinue their patients' anti-platelet therapy prior to surgery, a recent study of patients undergoing carotid endarterectomy (CEA) indicated that this practice may be unnecessary.

13 Dec 2010

Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer.

13 Dec 2010

Combination of SPECT and CT scans could offer protection against lymphedema in breast cancer patients

With guidance from a specialized scan, radiation oncologists at Mayo Clinic were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses.

13 Dec 2010

Do not delay breast cancer therapy during pregnancy

Do not delay treatment of breast cancer just because a woman is pregnant, said lead researcher Sibylle Loibl, Dr. med, of the German Breast Group.

13 Dec 2010

Stem cell biology offers great hope for eventual repair of body parts

Remarkable progress in understanding how stem cell biology works has been reported by a team of leading scientists, directed by experts at UC Santa Barbara. Their research has been published in the journal Cell Stem Cell.

13 Dec 2010

Scientists demonstrate triple-drug cocktail for triple negative breast cancer at AACR symposium

A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.

13 Dec 2010

EMEA calls for Europe-wide ban on blood donation from ME/CFS patients

The European ME Alliance (EMEA) is calling on Europe's health ministers to initiate an immediate Europe-wide prohibition of blood donation from people who have been diagnosed with myalgic encephalomyelitis (ME/CFS).

13 Dec 2010

Researchers conduct trial to study obesity-related respiratory limitations on weight loss

Tamara Ritchie lost 25 pounds in 12 weeks without breaking a sweat. She was just following doctors' orders.

13 Dec 2010

Cancer researchers identify six gene markers in early stage NSCLC

Cancer researchers have identified six gene markers present in early stage non-small cell lung cancer (NSCLC) that show promise in helping oncologists better identify which tumors will relapse after curative surgery, according to a study presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology.

13 Dec 2010

Excess weight gain during winter holidays increases back injury

Thousands of Americans sustain winter-related back injuries every year, including many injuries directly related to holiday activities. But there are often simple things that can be done to reduce injury risk and minimize or eliminate back pain.

13 Dec 2010

New initiative launched to fight cystic fibrosis

The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian technologies that will help combat cystic fibrosis (CF).

13 Dec 2010

Boehringer Ingelheim reports positive results from afatinib phase IIb/III LUX-Lung 1 trial in advanced NSCLC

Boehringer Ingelheim Pharmaceuticals, Inc. announced that new data from a subgroup analysis of the phase IIb/III LUX-Lung 1 trial show that afatinib (BIBW 2992) reached a four-fold extension (4.4 months vs. 1.0 month for placebo) in progression-free survival (PFS) in advanced non-small cell lung cancer (NSCLC) patients most likely to have an epidermal growth factor receptor (EGFR) mutation. The updated LUX-Lung 1 data will be presented at the Chicago Multidisciplinary Symposium in Thoracic Oncology.

13 Dec 2010

Medical Condition News

iTech Medical receives Health Canada approval for Muscle Pattern Recognition System

Ascension Orthopedics reports first implantation of PyroTITAN Humeral Resurfacing Implant in France

New positive data on Generex Oral-lyn published in Diabetes, Obesity and Metabolism

Fracture risk assessment tool for Singaporeans released

Vical's Vaxfectin adjuvant boosts immune response of DNA-based vaccines against cancer

Stimatix GI's AOS-C1000 colostomy management device meets primary, secondary endpoints in pre-clinical studies

Man Up Now capsules can dangerously lower blood pressure

School children who dislike fruits and vegetables are more likely to develop functional constipation

Researchers examine outcomes related to antiplatelet therapy in patients undergoing CEA

Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

Combination of SPECT and CT scans could offer protection against lymphedema in breast cancer patients

Do not delay breast cancer therapy during pregnancy

Stem cell biology offers great hope for eventual repair of body parts

Scientists demonstrate triple-drug cocktail for triple negative breast cancer at AACR symposium

EMEA calls for Europe-wide ban on blood donation from ME/CFS patients

Researchers conduct trial to study obesity-related respiratory limitations on weight loss

Cancer researchers identify six gene markers in early stage NSCLC

Excess weight gain during winter holidays increases back injury

New initiative launched to fight cystic fibrosis

Boehringer Ingelheim reports positive results from afatinib phase IIb/III LUX-Lung 1 trial in advanced NSCLC

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News